We have previously shown that in the steady state CD11c+ DCs are necessary for crosspresentation to tumor-specific CD8+ T cells in dLN, as CD8+ T cell proliferation was abrogated in mice depleted of CD11c+ cells (9). This evidence concerns the gene ITGAX and neoplasm.